Filing Details

Accession Number:
0000899243-21-025527
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-23 18:44:25
Reporting Period:
2021-06-21
Accepted Time:
2021-06-23 18:44:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
749660 Icad Inc ICAD Surgical & Medical Instruments & Apparatus (3841) 020377419
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362512 M Stacey Stevens C/O Icad Inc
98 Spit Brook Road Suite 100
Nashua NH 03062
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-21 2,690 $18.02 149,098 No 4 S Direct
Common Stock Disposition 2021-06-21 6,476 $18.02 142,622 No 4 S Direct
Common Stock Acquisiton 2021-06-21 235 $6.68 142,857 No 4 M Direct
Common Stock Disposition 2021-06-21 236 $18.34 142,621 No 4 S Direct
Common Stock Acquisiton 2021-06-21 8,333 $4.38 150,954 No 4 M Direct
Common Stock Disposition 2021-06-21 8,333 $18.02 142,621 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-06-21 235 $0.00 235 $6.68
Common Stock Employee Stock Option (right to buy) Disposition 2021-06-21 8,333 $0.00 8,333 $4.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-06-19 2024-06-19 No 4 M Direct
0 2021-03-25 2029-03-25 No 4 M Direct
Footnotes
  1. Represents the number of shares sold by the Reporting Person in broker-assisted "sell-to-cover" transactions, to cover tax withholding obligations in connection with the vesting of restricted shares, granted to the Reporting Person under the Issuer's 2016 Stock Incentive Plan.
  2. Represents shares sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.76 to $18.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on June 21, 2021.